We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CORT icon
1176
Corcept Therapeutics
CORT
$11.9B
$731K 0.01%
43,446
DLPH
1177
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$729K 0.01%
51,279
+1,873
+4% +$21K
PTEN icon
1178
Patterson-UTI
PTEN
$4.16B
$727K 0.01%
209,543
-26,568
-11% -$91.6K
GKOS icon
1179
Glaukos
GKOS
$11.2B
$726K 0.01%
18,906
+2,196
+13% +$81.8K
AMBA icon
1180
Ambarella
AMBA
$3.6B
$726K 0.01%
15,846
+1,790
+13% +$92.2K
EGHT icon
1181
8x8 Inc
EGHT
$303M
$724K 0.01%
45,228
+4,163
+10% +$66.1K
IRWD icon
1182
Ironwood Pharmaceuticals
IRWD
$674M
$722K 0.01%
69,963
TERP
1183
DELISTED
TerraForm Power, Inc
TERP
$719K 0.01%
39,014
+4,125
+12% +$73K
BIG
1184
DELISTED
Big Lots, Inc.
BIG
$716K 0.01%
17,050
MTSI icon
1185
MACOM Technology Solutions
MTSI
$23.5B
$716K 0.01%
20,841
+1,857
+10% +$54.2K
HTO
1186
H2O America
HTO
$2.65B
$715K 0.01%
11,504
+678
+6% +$40.7K
HRB icon
1187
H&R Block
HRB
$6.76B
$713K 0.01%
49,916
-411
-0.8% -$6.5K
SUN icon
1188
Sunoco
SUN
$14B
$711K 0.01%
31,130
AQUA
1189
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$710K 0.01%
38,194
+3,350
+10% +$55.4K
RPAI
1190
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
$708K 0.01%
+96,675
New +$557K
SEM
1191
DELISTED
Select Medical
SEM
$706K 0.01%
88,943
NGHC
1192
DELISTED
National General Holdings Corp
NGHC
$705K 0.01%
32,641
+4,091
+14% +$77K
ABCB icon
1193
Ameris Bancorp
ABCB
$6B
$705K 0.01%
29,870
+3,115
+12% +$73.1K
GAP
1194
The Gap Inc
GAP
$7.34B
$703K 0.01%
55,675
+829
+2% +$7.47K
MOG.A icon
1195
Moog Inc Class A
MOG.A
$13.5B
$700K 0.01%
13,220
IBP icon
1196
Installed Building Products
IBP
$6.54B
$699K 0.01%
10,156
+687
+7% +$38.1K
KOD icon
1197
Kodiak Sciences
KOD
$2.5B
$698K 0.01%
12,892
+795
+7% +$44.8K
UCB
1198
United Community Banks
UCB
$4.43B
$695K 0.01%
34,521
BGS icon
1199
B&G Foods
BGS
$299M
$693K 0.01%
28,438
+1,879
+7% +$40.7K
ONTO icon
1200
Onto Innovation
ONTO
$20.6B
$693K 0.01%
20,367

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.